/ 
/ 
Poly ICLC
From Wikipedia, the free encyclopedia
|
Poly ICLC
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | ? |
| ATC code | L03 |
| PubChem | ? |
| Chemical data | |
| Formula | ? |
| Mol. mass | ? |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Poly ICLC is an immunostimulant.
It consists of carboxymethylcellulose, polyinosinic-polycytidylic acid, and poly-L-lysine double-stranded RNA.[1]
It is a ligand for toll like receptor-3.[2]
[edit] References
- ^ "Definition of poly ICLC - National Cancer Institute Drug Dictionary". Retrieved on 2007-11-13.
- ^ Zhu X, Nishimura F, Sasaki K, et al (2007). "Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models". Journal of translational medicine 5: 10. doi:. PMID 17295916.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||
http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=39559